Articles with public access mandates - Samuele Cortese, M.D., Ph.D.Learn more
Not available anywhere: 20
Review
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents
S Cortese, M Holtmann, T Banaschewski, J Buitelaar, D Coghill, ...
Journal of Child Psychology and Psychiatry 54 (3), 227-246, 2013
Mandates: US National Institutes of Health, German Research Foundation
Review
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries
M Solmi, M Song, DK Yon, SW Lee, E Fombonne, MS Kim, S Park, ...
Molecular Psychiatry 27 (10), 4172-4180, 2022
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Review
Gender differences in adult attention-deficit/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
S Cortese, SV Faraone, S Bernardi, S Wang, C Blanco
The Journal of clinical psychiatry 77 (4), 7626, 2016
Mandates: US National Institutes of Health
Review
A 4-year follow-up of attention-deficit/hyperactivity disorder in a population sample
M Lecendreux, E Konofal, S Cortese, SV Faraone
The Journal of Clinical Psychiatry 76 (6), 7387, 2015
Mandates: US National Institutes of Health
Review
Attention-deficit/hyperactivity disorder, iron deficiency, and obesity: is there a link?
S Cortese, M Angriman
Postgraduate Medicine 126 (4), 155-170, 2014
Mandates: European Commission
Review
The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis
LC Farhat, JM Flores, E Behling, VJ Avila-Quintero, A Lombroso, ...
Molecular psychiatry 27 (3), 1562-1572, 2022
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …
Review
A practical, evidence-informed approach to managing stimulant-refractory attention deficit hyperactivity disorder (ADHD)
S Cortese, JH Newcorn, D Coghill
CNS drugs 35 (10), 1035-1051, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis
R Massuti, CR Moreira-Maia, F Campani, M Sônego, J Amaro, ...
Neuroscience & Biobehavioral Reviews 128, 64-73, 2021
Mandates: Bill & Melinda Gates Foundation
Review
A 9-Year follow-up of Attention-Deficit/Hyperactivity Disorder in a population sample
M Lecendreux, M Silverstein, E Konofal, S Cortese, SV Faraone
The Journal of Clinical Psychiatry 80 (3), 15128, 2019
Mandates: European Commission
Review
Nonstimulant medications for attention-deficit/hyperactivity disorder (ADHD) in adults: systematic review and meta-analysis
NV Radonjić, A Bellato, NM Khoury, S Cortese, SV Faraone
CNS drugs 37 (5), 381-397, 2023
Mandates: US National Institutes of Health, European Commission
Review
Incidence of adverse events and comparative tolerability of selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for the treatment of …
NP Gosmann, M de Abreu Costa, M de Barros Jaeger, J Frozi, ...
Psychological Medicine 53 (9), 3783-3792, 2023
Mandates: US National Institutes of Health
Review
Cognitive and behavioral profiles in children with autism spectrum disorder with and without Attention‐Deficit/hyperactivity disorder
R Rosello, J Martinez‐Raga, JM Tomas, A Mira, S Cortese
Child and Adolescent Mental Health 28 (2), 269-276, 2023
Mandates: Government of Spain
Review
Exploring developmental trajectories throughout adolescence of children with autism spectrum disorder without intellectual disability
R Rosello, J Martinez-Raga, JM Tomas, B Rosello, C Berenguer, ...
Journal of Neural Transmission 130 (3), 299-312, 2023
Mandates: Government of Spain
Review
Shared and specific neural correlates of attention deficit hyperactivity disorder and autism spectrum disorder: a meta-analysis of 243 task-based functional MRI studies
H Tamon, J Fujino, T Itahashi, L Frahm, V Parlatini, YY Aoki, ...
American Journal of Psychiatry, appi. ajp. 20230270, 2024
Mandates: National Institute for Health Research, UK, European Commission
Review
Treatment outcomes with licensed and unlicensed stimulant doses for adults with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis
LC Farhat, JM Flores, VJ Avila-Quintero, GV Polanczyk, A Cipriani, ...
JAMA psychiatry, 2024
Mandates: National Institute for Health Research, UK, Wellcome Trust
Review
Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review
M Solmi, A Miola, F Capone, S Pallottino, M Højlund, J Firth, D Siskind, ...
Expert Opinion on Drug Safety, 2024
Mandates: National Health and Medical Research Council, Australia, UK Research …
Review
Electronic Health Records for Research on Attention-Deficit/Hyperactivity Disorder Pharmacotherapy: A Comprehensive Review
S Roy, L Arturi, V Parlatini, S Cortese
Journal of Child and Adolescent Psychopharmacology, 2024
Mandates: National Institute for Health Research, UK, European Commission
Review
Reply: the inclusion of methylphenidate in the WHO list of essential medicines is endorsed by millions of people with ADHD
S Cortese, D Coghill, JM Fegert, GW Mattingly, LA Rohde, ICK Wong, ...
European Child & Adolescent Psychiatry, 1-3, 2024
Mandates: National Institute for Health Research, UK, European Commission
Review
Original Research A 4-Year Follow-Up of Attention-Deficit/Hyperactivity Disorder
M Lecendreux, E Konofal, S Cortese, SV Faraone
J Clin Psychiatry 76 (6), 712-719, 2015
Mandates: US National Institutes of Health
Review
journal homepage: www. elsevier. com/locate/mehy
J Alisky, MSE Alves, P Angadi, M Angriman, A Antunes, R Aquaron, ...
Medical Hypotheses 79, 898-901, 2012
Mandates: National Institute of Health and Medical Research, France
Publication and funding information is determined automatically by a computer program